Time to let go of the biopsy? A new era in cardiac rejection monitoring?
Heart transplantation (HTx) is the optimal treatment for advanced heart failure in selected patients. Acute rejection is a potentially fatal complication. Endomyocardial biopsy (EMB) is still considered the gold standard for diagnosis of acute rejection according to current guidelines from the International Society of Heart and Lung Transplantation.1
Authors
- MJ. Andersen
- TS. Clemmensen
- H. Eiskjaer
Institutions
- Aarhus University Hospital (DK)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100478
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00